Calcitriol Concentration in the Early Phase of Myocardial Infarction and Its Relation to Left Ventricular Ejection Fraction
- PMID: 39728467
- PMCID: PMC11677622
- DOI: 10.3390/metabo14120686
Calcitriol Concentration in the Early Phase of Myocardial Infarction and Its Relation to Left Ventricular Ejection Fraction
Abstract
Vitamin D deficiency is one of the most common metabolic disorders in the European population. A low level of 25-OH vitamin D3 is related to an elevated risk of myocardial infarction (MI). The aim of our study was to examine the relationship between calcidiol and calcitriol serum concentration and left ventricular ejection fraction early after interventional treatment for acute coronary syndrome. A total of 80 patients diagnosed with MI, who underwent primary percutaneous coronary intervention, were included in the study. Blood samples for calcidiol, calcitriol, and vitamin D-binding protein were obtained 24 h after primary PCI and were measured using an enzyme-linked immunosorbent assay. Only 9% of patients had a proper level of 25-OHD3 in the serum (30-80 ng/mL). A total of 16% of patients revealed a suboptimal concentration of 25-OHD3 (20-30 ng/mL), and in 75% of patients, the concentration of 25-OHD3 was lower than 20 ng/mL. Moreover, patients with left ventricle ejection fraction of <40% had significantly lower concentrations of calcidiol and calcitriol. A low calcitriol serum concentration affects post-MI left ventricle ejection fraction early after myocardial infarction onset. It seems that 1.25(OH)D3 may contribute to acute myocardial infarction; however, there are insufficient clinical trials related to this topic, and the available evidence is mainly from in vitro studies. We hope these preliminary reports will provide a better understanding of post-MI.
Keywords: calcitriol; myocardial infarction; vitamin D.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.J Thromb Thrombolysis. 2005 Dec;20(3):147-53. doi: 10.1007/s11239-005-3267-4. J Thromb Thrombolysis. 2005. PMID: 16261287 Clinical Trial.
-
Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction.Prilozi. 2007 Jul;28(1):23-38. Prilozi. 2007. PMID: 17921916
-
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].Nefrologia. 2008;28 Suppl 3:67-78. Nefrologia. 2008. PMID: 19018742 Spanish.
-
Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance.Scand J Clin Lab Invest Suppl. 1997;227:35-45. Scand J Clin Lab Invest Suppl. 1997. PMID: 9127467 Review.
-
Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials.Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):469-477. doi: 10.1177/2048872619830609. Epub 2019 Feb 14. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 30759994 Free PMC article. Review.
References
-
- 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population–PubMed. [(accessed on 28 June 2024)]; Available online: https://pubmed.ncbi.nlm.nih.gov/18695076/
-
- Meems L.M., Brouwers F.P., Joosten M.M., Lambers Heerspink H.J., de Zeeuw D., Bakker S.J., Gansevoort R.T., van Gilst W.H., van der Harst P., de Boer R.A. Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study. ESC Heart Fail. 2016;3:189–197. doi: 10.1002/ehf2.12089. - DOI - PMC - PubMed
-
- Reddy Y.N.V., Lewis G.D., Shah S.J., LeWinter M., Semigran M., Davila-Roman V.G., Anstrom K., Hernandez A., Braunwald E., Redfield M.M., et al. INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design. Circ Heart Fail. 2017;10:e003862. doi: 10.1161/CIRCHEARTFAILURE.117.003862. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous